1. Home
  2. OPK vs BFS Comparison

OPK vs BFS Comparison

Compare OPK & BFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • BFS
  • Stock Information
  • Founded
  • OPK 2007
  • BFS 1993
  • Country
  • OPK United States
  • BFS United States
  • Employees
  • OPK N/A
  • BFS N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • BFS Real Estate Investment Trusts
  • Sector
  • OPK Health Care
  • BFS Real Estate
  • Exchange
  • OPK Nasdaq
  • BFS Nasdaq
  • Market Cap
  • OPK 1.0B
  • BFS 985.6M
  • IPO Year
  • OPK 1995
  • BFS 1993
  • Fundamental
  • Price
  • OPK $1.46
  • BFS $39.87
  • Analyst Decision
  • OPK Strong Buy
  • BFS Strong Buy
  • Analyst Count
  • OPK 3
  • BFS 1
  • Target Price
  • OPK $2.75
  • BFS $45.50
  • AVG Volume (30 Days)
  • OPK 2.6M
  • BFS 47.4K
  • Earning Date
  • OPK 11-04-2024
  • BFS 11-04-2024
  • Dividend Yield
  • OPK N/A
  • BFS 5.94%
  • EPS Growth
  • OPK N/A
  • BFS 8.84
  • EPS
  • OPK N/A
  • BFS 1.78
  • Revenue
  • OPK $716,372,000.00
  • BFS $264,084,000.00
  • Revenue This Year
  • OPK N/A
  • BFS N/A
  • Revenue Next Year
  • OPK $1.36
  • BFS $6.21
  • P/E Ratio
  • OPK N/A
  • BFS $22.32
  • Revenue Growth
  • OPK N/A
  • BFS 5.56
  • 52 Week Low
  • OPK $0.85
  • BFS $33.69
  • 52 Week High
  • OPK $1.75
  • BFS $42.19
  • Technical
  • Relative Strength Index (RSI)
  • OPK 44.03
  • BFS 42.98
  • Support Level
  • OPK $1.44
  • BFS $40.24
  • Resistance Level
  • OPK $1.56
  • BFS $41.19
  • Average True Range (ATR)
  • OPK 0.06
  • BFS 0.62
  • MACD
  • OPK -0.00
  • BFS -0.14
  • Stochastic Oscillator
  • OPK 26.67
  • BFS 23.19

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.

About BFS Saul Centers Inc.

Saul Centers Inc is a self-managed real estate investment trust which invests in, operates, and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.

Share on Social Networks: